- Home
- CANG vs LAB Comparison
CANG vs LAB Comparison
Compare CANG & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANG
- LAB
- Stock Information
- Founded
- CANG 2010
- LAB 1999
- Country
- CANG China
- LAB United States
- Employees
- CANG N/A
- LAB N/A
- Industry
- CANG Computer Software: Prepackaged Software
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- CANG Technology
- LAB Industrials
- Exchange
- CANG Nasdaq
- LAB Nasdaq
- Market Cap
- CANG 462.1M
- LAB 372.1M
- IPO Year
- CANG 2018
- LAB 2011
- Fundamental
- Price
- CANG $5.24
- LAB $1.35
- Analyst Decision
- CANG
- LAB Buy
- Analyst Count
- CANG 0
- LAB 2
- Target Price
- CANG N/A
- LAB $2.50
- AVG Volume (30 Days)
- CANG 440.1K
- LAB 2.6M
- Earning Date
- CANG 08-28-2025
- LAB 07-30-2025
- Dividend Yield
- CANG N/A
- LAB N/A
- EPS Growth
- CANG N/A
- LAB N/A
- EPS
- CANG 0.00
- LAB N/A
- Revenue
- CANG $247,219,627.00
- LAB $169,687,000.00
- Revenue This Year
- CANG $431.64
- LAB N/A
- Revenue Next Year
- CANG $23.36
- LAB $12.18
- P/E Ratio
- CANG $2,769.28
- LAB N/A
- Revenue Growth
- CANG 46.60
- LAB 33.86
- 52 Week Low
- CANG $1.40
- LAB $0.92
- 52 Week High
- CANG $9.66
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- CANG 62.58
- LAB 64.54
- Support Level
- CANG $4.26
- LAB $1.15
- Resistance Level
- CANG $4.62
- LAB $1.31
- Average True Range (ATR)
- CANG 0.29
- LAB 0.11
- MACD
- CANG 0.05
- LAB 0.03
- Stochastic Oscillator
- CANG 92.68
- LAB 57.89
About CANG Cango Inc. each representing two (2)
Cango Inc through its subsidiaries, variable interest entities (VIEs), and subsidiaries of the VIEs, are principally engaged in bitcoin mining business, and the automobile trading transaction, automotive financing facilitation, and aftermarket service facilitation businesses (collectively, the automobile and related businesses). The Company conducts the bitcoin mining business mainly through its subsidiaries, and the automobile and related businesses are conducted through the Company's VIEs and the subsidiaries of the VIEs. The company derives majority of its revenue from the bitcoin mining business.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.